Raloxifene, manufactured by Eli Lilly & Co.(NYSE:LLY) is a drug known as a selective estrogen receptor modulator (SERM). It block seems to block estrogen receptors in the breast thus reducing the risk of invasive breast cancer. The side effects are severe and can include blood clots, hot flashes, leg cramps, flu-like symptoms, joint pain and sweating.
Invasive breast cancer accounts for more the 25% of cancers in women and the American Cancer Society estimates that over 178,000 women will be diagnosed with it this year.
Comment Preview